Skip to main content
logo
Valion Bio, Inc. (VBIO)
NASDAQ: VBIO · Real-Time Price · USD
0.2854
+0.0105 (3.82%)
At close: Aug 7, 2026, 4:00 PM EDT
0.2770
-0.0084 (-2.94%)
After-hours: Aug 7, 2026, 7:45 PM EDT

Valion Bio Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.23--1.181.841.26
Revenue Growth
-12.78%---36.09%46.38%46.16%
Gross Profit
-0.09--0.290.3-0.04
Operating Income
-12.03-7.9-4.48-8.25-10.1-5.63
Net Income
-13.58-8.88-5.66-8.24-10.1-8.49
Earnings Per Share
-7.74-7.84-19.68-176.80--
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
7.2212.6523.43.5212.98
Total Debt
17.036.4500.370.530.71
Net Cash (Debt)
-9.826.1923.032.9912.27
Net Cash Growth
-209.24%-33.84%1.31%-75.65%-
Net Cash Per Share
-5.675.366.9764.87--

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-11.12-7-5.73-8.51-8.92-5.61
Capital Expenditures
-0.05-0.04--0.12-0.01-
Free Cash Flow
-11.17-7.04-5.73-8.63-8.93-5.61
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-39.22%--24.40%16.25%-3.02%
Operating Margin
-5183.62%---701.11%-548.80%-448.13%
Pretax Margin
-5481.03%---701.02%-548.70%-675.74%
Profit Margin
-5481.03%---701.02%-548.70%-675.74%
FCF Margin
-4812.93%---733.76%-485.33%-446.46%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
---0.010.020.15